Filed: 8/14/2025ACC: 0001937964-25-000006
📋 What this filing means
ARTIA GLOBAL PARTNERS LP filed this quarterly 13F‑HR report disclosing 35 equity positions with a total reported market value of $415.64M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
35
Positions
$415.64M
Total AUM (reported)
6.39M
Total Shares
Allocation by class
COM$161.47M38.8%
SPONSORED ADS$96.09M23.1%
COM PAR $.01$79.78M19.2%
SPONSORED ADR$58.61M14.1%
S&P BIOTECH$8.29M2.0%
ULTRA GOLD$5.82M1.4%
COM NEW$2.98M0.7%
Portfolio Concentration
Top 3$219.04M52.7%
4–10$133.94M32.2%
11–25$53.97M13.0%
Rest$8.70M2.1%
Top 3 weight
52.7%
Top 10 weight
84.9%
Voting Authority Distribution
Total shares with voting rights: 6.39M
Sole
Full voting authority
6.39M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole35
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings35
Rows:
VERONA PHARMA PLC
SOLEShares1.02M
TypeSH
Market value$96.09M
23.12%
Sole
1.02M
Shared
0.00
None
0.00
INSMED INC
SOLEShares792.71K
TypeSH
Market value$79.78M
19.19%
Sole
792.71K
Shared
0.00
None
0.00
ARGENX SE
SOLEShares78.31K
TypeSH
Market value$43.17M
10.39%
Sole
78.31K
Shared
0.00
None
0.00
SOLENO THERAPEUTICS INC
SOLEShares494.42K
TypeSH
Market value$41.42M
9.97%
Sole
494.42K
Shared
0.00
None
0.00
ELI LILLY & CO
SOLEShares30.70K
TypeSH
Market value$23.93M
5.76%
Sole
30.70K
Shared
0.00
None
0.00
BOSTON SCIENTIFIC CORP
SOLEShares155.20K
TypeSH
Market value$16.67M
4.01%
Sole
155.20K
Shared
0.00
None
0.00
MERUS N V
SOLEShares296.75K
TypeSH
Market value$15.61M
3.76%
Sole
296.75K
Shared
0.00
None
0.00
QUEST DIAGNOSTICS INC
SOLEShares81.72K
TypeSH
Market value$14.68M
3.53%
Sole
81.72K
Shared
0.00
None
0.00
ASTRAZENECA PLC
SOLEShares190.75K
TypeSH
Market value$13.33M
3.21%
Sole
190.75K
Shared
0.00
None
0.00
SPDR SER TR
SOLEShares100K
TypeSH
Market value$8.29M
2.00%
Sole
100K
Shared
0.00
None
0.00
TREVI THERAPEUTICS INC
SOLEShares1.31M
TypeSH
Market value$7.18M
1.73%
Sole
1.31M
Shared
0.00
None
0.00
ALNYLAM PHARMACEUTICALS INC
SOLEShares20.97K
TypeSH
Market value$6.84M
1.65%
Sole
20.97K
Shared
0.00
None
0.00
PROSHARES TR II
SOLEShares168K
TypeSH
Market value$5.82M
1.40%
Sole
168K
Shared
0.00
None
0.00
REGENERON PHARMACEUTICALS
SOLEShares10.67K
TypeSH
Market value$5.60M
1.35%
Sole
10.67K
Shared
0.00
None
0.00
SCHOLAR ROCK HLDG CORP
SOLEShares126.28K
TypeSH
Market value$4.47M
1.08%
Sole
126.28K
Shared
0.00
None
0.00
REVOLUTION MEDICINES INC
SOLEShares104.19K
TypeSH
Market value$3.83M
0.92%
Sole
104.19K
Shared
0.00
None
0.00
SPRINGWORKS THERAPEUTICS INC
SOLEShares63.93K
TypeSH
Market value$3.00M
0.72%
Sole
63.93K
Shared
0.00
None
0.00
EYEPOINT PHARMACEUTICALS INC
SOLEShares316.70K
TypeSH
Market value$2.98M
0.72%
Sole
316.70K
Shared
0.00
None
0.00
ABBVIE INC
SOLEShares14.50K
TypeSH
Market value$2.69M
0.65%
Sole
14.50K
Shared
0.00
None
0.00
VIKING THERAPEUTICS INC
SOLEShares96.48K
TypeSH
Market value$2.56M
0.62%
Sole
96.48K
Shared
0.00
None
0.00
ASCENDIS PHARMA A/S
SOLEShares12.24K
TypeSH
Market value$2.11M
0.51%
Sole
12.24K
Shared
0.00
None
0.00
TG THERAPEUTICS INC
SOLEShares54.52K
TypeSH
Market value$1.96M
0.47%
Sole
54.52K
Shared
0.00
None
0.00
VERTEX PHARMACEUTICALS INC
SOLEShares4.40K
TypeSH
Market value$1.96M
0.47%
Sole
4.40K
Shared
0.00
None
0.00
ULTRAGENYX PHARMACEUTICAL IN
SOLEShares41.83K
TypeSH
Market value$1.52M
0.37%
Sole
41.83K
Shared
0.00
None
0.00
UNITED THERAPEUTICS CORP DEL
SOLEShares5K
TypeSH
Market value$1.44M
0.35%
Sole
5K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
VERONA PHARMA PLCSOLE | SPONSORED ADS | 1.02M | SH | $96.09M 23.12% | 1.02M | 0.00 | 0.00 |
INSMED INCSOLE | COM PAR $.01 | 792.71K | SH | $79.78M 19.19% | 792.71K | 0.00 | 0.00 |
ARGENX SESOLE | SPONSORED ADR | 78.31K | SH | $43.17M 10.39% | 78.31K | 0.00 | 0.00 |
SOLENO THERAPEUTICS INCSOLE | COM | 494.42K | SH | $41.42M 9.97% | 494.42K | 0.00 | 0.00 |
ELI LILLY & COSOLE | COM | 30.70K | SH | $23.93M 5.76% | 30.70K | 0.00 | 0.00 |
BOSTON SCIENTIFIC CORPSOLE | COM | 155.20K | SH | $16.67M 4.01% | 155.20K | 0.00 | 0.00 |
MERUS N VSOLE | COM | 296.75K | SH | $15.61M 3.76% | 296.75K | 0.00 | 0.00 |
QUEST DIAGNOSTICS INCSOLE | COM | 81.72K | SH | $14.68M 3.53% | 81.72K | 0.00 | 0.00 |
ASTRAZENECA PLCSOLE | SPONSORED ADR | 190.75K | SH | $13.33M 3.21% | 190.75K | 0.00 | 0.00 |
SPDR SER TRSOLE | S&P BIOTECH | 100K | SH | $8.29M 2.00% | 100K | 0.00 | 0.00 |
TREVI THERAPEUTICS INCSOLE | COM | 1.31M | SH | $7.18M 1.73% | 1.31M | 0.00 | 0.00 |
ALNYLAM PHARMACEUTICALS INCSOLE | COM | 20.97K | SH | $6.84M 1.65% | 20.97K | 0.00 | 0.00 |
PROSHARES TR IISOLE | ULTRA GOLD | 168K | SH | $5.82M 1.40% | 168K | 0.00 | 0.00 |
REGENERON PHARMACEUTICALSSOLE | COM | 10.67K | SH | $5.60M 1.35% | 10.67K | 0.00 | 0.00 |
SCHOLAR ROCK HLDG CORPSOLE | COM | 126.28K | SH | $4.47M 1.08% | 126.28K | 0.00 | 0.00 |
REVOLUTION MEDICINES INCSOLE | COM | 104.19K | SH | $3.83M 0.92% | 104.19K | 0.00 | 0.00 |
SPRINGWORKS THERAPEUTICS INCSOLE | COM | 63.93K | SH | $3.00M 0.72% | 63.93K | 0.00 | 0.00 |
EYEPOINT PHARMACEUTICALS INCSOLE | COM NEW | 316.70K | SH | $2.98M 0.72% | 316.70K | 0.00 | 0.00 |
ABBVIE INCSOLE | COM | 14.50K | SH | $2.69M 0.65% | 14.50K | 0.00 | 0.00 |
VIKING THERAPEUTICS INCSOLE | COM | 96.48K | SH | $2.56M 0.62% | 96.48K | 0.00 | 0.00 |
ASCENDIS PHARMA A/SSOLE | SPONSORED ADR | 12.24K | SH | $2.11M 0.51% | 12.24K | 0.00 | 0.00 |
TG THERAPEUTICS INCSOLE | COM | 54.52K | SH | $1.96M 0.47% | 54.52K | 0.00 | 0.00 |
VERTEX PHARMACEUTICALS INCSOLE | COM | 4.40K | SH | $1.96M 0.47% | 4.40K | 0.00 | 0.00 |
ULTRAGENYX PHARMACEUTICAL INSOLE | COM | 41.83K | SH | $1.52M 0.37% | 41.83K | 0.00 | 0.00 |
UNITED THERAPEUTICS CORP DELSOLE | COM | 5K | SH | $1.44M 0.35% | 5K | 0.00 | 0.00 |
Page 1 of 2